Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$127.77

1.77 (1.40%)

20:01
07/12/18
07/12
20:01
07/12/18
20:01

Johnson & Johnson responds to $4.69B verdict against company

The company states: "Johnson & Johnson is deeply disappointed in the verdict, which was the product of a fundamentally unfair process that allowed plaintiffs to present a group of 22 women, most of whom had no connection to Missouri, in a single case all alleging that they developed ovarian cancer. The result of the verdict, which awarded the exact same amounts to all plaintiffs irrespective of their individual facts, and differences in applicable law, reflects that the evidence in the case was simply overwhelmed by the prejudice of this type of proceeding. Johnson & Johnson remains confident that its products do not contain asbestos and do not cause ovarian cancer and intends to pursue all available appellate remedies. Every verdict against Johnson & Johnson in this court that has gone through the appeals process has been reversed and the multiple errors present in this trial were worse than those in the prior trials which have been reversed."

  • 17

    Jul

JNJ Johnson & Johnson
$127.77

1.77 (1.40%)

07/06/18
RBCM
07/06/18
NO CHANGE
Target $143
RBCM
Outperform
Johnson & Johnson price target lowered to $143 from $155 at RBC Capital
RBC Capital analyst Glenn Novarro lowered his price target on Johnson & Johnson to $143 ahead of its Q2 results, saying the trends in the U.S. prescription drug market suggest that any upside in the company's Pharmaceutical segment is unlikely. Novarro expects the management to affirm its FY18 guidance for operational growth and earnings, but warns that the revenue guidance may see a downgrade due to the recent USD strength. The analyst also lowered his FY18 revenue projections to $81.1B from $81.3B and FY19 forecast to $80.6B from $83.0B.
07/11/18
WELS
07/11/18
NO CHANGE
WELS
Drug stocks may not react favorably to Pfizer price rollback, Trump tweets, says Wells Fargo
Wells Fargo analyst David Maris notes that there was widespread media coverage of drug price increases taken recently by several large cap drug companies, with President Trump criticizing Pfizer (PFE) for taking these price increases. On Tuesday, Pfizer confirmed it was rolling back its July drug price increases following a conversation with President Trump, he adds. Maris believes that drug stocks will not react favorably to this news, given the chilling effect this will likely have on others looking to take price increases. Nonetheless, the analyst points out that the price increases taken in July are only a small number of increases taken over the past year or several years, so the impact of the rollback to the healthcare system is insignificant in the big picture. Other publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
07/12/18
GSCO
07/12/18
UPGRADE
GSCO
Neutral
Johnson & Johnson upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Jami Rubin upgraded Johnson & Johnson (JNJ) to Neutral with an unchanged price target of $134. The shares closed yesterday down $1.11 to $126.24. The stock is down 10% year-to-date and 15% from its recent all-time high of $148, Rubin tells investors in a research note. She notes J&J is trading in line with the large cap Pharmaceuticals group at 15 times 2019 estimates. The company's non-operational earnings revisions are now better understood by investors at current share levels, Rubin contends. The analyst this morning also downgraded Perrigo (PRGO) to Sell from Neutral.
07/12/18
07/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Johnson & Johnson (JNJ) upgraded to Neutral from Sell at Goldman Sachs with analyst Jami Rubin saying the stock is down 10% year-to-date and 15% from its recent all-time high of $148. 2. Hallmark Financial (HALL) upgraded to Outperform from Market Perform at Raymond James. 3. Transocean (RIG), Ensco (ESV), and Rowan Companies (RDC) were upgraded to Buy from Hold at Tudor Pickering. 4. Precision Drilling (PDS) and Nabors Industries (NBR) were upgraded to Overweight from Equal Weight at Morgan Stanley. 5. CA Technologies (CA) upgraded to Market Perform from Underperform at Wells Fargo and Bernstein. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DFS

Discover

$71.52

-0.57 (-0.79%)

16:56
07/19/18
07/19
16:56
07/19/18
16:56
Hot Stocks
Discover announces new $3B share repurchase plan, raises dividend to 40c »

Discover announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

DFS

Discover

$71.52

-0.57 (-0.79%)

16:55
07/19/18
07/19
16:55
07/19/18
16:55
Hot Stocks
Breaking Hot Stocks news story on Discover »

Discover announces new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

16:55
07/19/18
07/19
16:55
07/19/18
16:55
Conference/Events
Stephens business services analyst to hold a dinner meeting »

Business Services Analyst…

WAL

Western Alliance

$58.12

-0.35 (-0.60%)

16:52
07/19/18
07/19
16:52
07/19/18
16:52
Earnings
Western Alliance reports Q2 EPS 99c, consensus 98c »

Reports Q2: net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 07

    Nov

JAZZ

Jazz Pharmaceuticals

$177.06

1.12 (0.64%)

16:47
07/19/18
07/19
16:47
07/19/18
16:47
Hot Stocks
JCO publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 20

    Dec

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

16:47
07/19/18
07/19
16:47
07/19/18
16:47
Hot Stocks
Intuitive Surgical says U.S. showed particular strength »

Says added surgical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 21

    Aug

  • 27

    Aug

NAVB

Navidea

$0.21

-0.0011 (-0.51%)

16:45
07/19/18
07/19
16:45
07/19/18
16:45
Conference/Events
Navidea to host business news update conference call »

President & CEO and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

NGVT

Ingevity

$90.05

0.07 (0.08%)

16:42
07/19/18
07/19
16:42
07/19/18
16:42
Hot Stocks
Ingevity files suit against BASF for infringing on canister systems patent »

Ingevity has taken…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTCT

PTC Therapeutics

$36.61

1.59 (4.54%)

16:40
07/19/18
07/19
16:40
07/19/18
16:40
Hot Stocks
Breaking Hot Stocks news story on PTC Therapeutics »

PTC Therapeutics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEHR

Aehr Test Systems

$2.81

0.13 (4.85%)

16:38
07/19/18
07/19
16:38
07/19/18
16:38
Earnings
Aehr Test Systems reports Q4 EPS 2c vs. (3c) in Q417 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

BANF

BancFirst

$62.05

0.2 (0.32%)

16:35
07/19/18
07/19
16:35
07/19/18
16:35
Earnings
BancFirst reports Q2 EPS 91c, consensus 85c »

Reports Q2 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENFC

Entegra Financial

$30.15

0.05 (0.17%)

16:34
07/19/18
07/19
16:34
07/19/18
16:34
Earnings
Entegra Financial reports Q2 core EPS 53c, consensus 56c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

GBCI

Glacier Bancorp

$40.38

0.12 (0.30%)

16:33
07/19/18
07/19
16:33
07/19/18
16:33
Earnings
Glacier Bancorp reports Q2 EPS 52c, consensus 53c »

The current quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

STXB

Spirit of Texas Bancshares

$20.45

0.12 (0.59%)

16:33
07/19/18
07/19
16:33
07/19/18
16:33
Hot Stocks
Spirit of Texas Bancshares to acquire Comanche National Corporation »

Spirit of Texas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

DATA

Tableau

$110.44

-0.76 (-0.68%)

16:32
07/19/18
07/19
16:32
07/19/18
16:32
Hot Stocks
Tableau names Damon Fletcher as CFO »

Tableau Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 16

    Aug

DAL

Delta Air Lines

$53.00

0.19 (0.36%)

16:31
07/19/18
07/19
16:31
07/19/18
16:31
Hot Stocks
Delta Air Lines, WestJet to create new transborder joint venture »

Delta Air Lines (NYSE:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
07/19/18
07/19
16:30
07/19/18
16:30
Options
Preliminary option volume of 18.4M today »

Preliminary option volume…

FIVE

Five Below

$107.80

0.93 (0.87%)

16:29
07/19/18
07/19
16:29
07/19/18
16:29
Hot Stocks
Five Below chairman Thomas Vellios sells over $6.1M in company shares »

The Five Below chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAM

First American

$10.06

-0.015 (-0.15%)

16:28
07/19/18
07/19
16:28
07/19/18
16:28
Hot Stocks
First American lowers monthly dividend to 7c from 7.5c per share »

The distribution will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$109.84

-1.17 (-1.05%)

16:27
07/19/18
07/19
16:27
07/19/18
16:27
Earnings
Celanese sees FY18 adjusted EPS $10.50-$10.75, consensus $9.64 »

Sees FY18 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 02

    Aug

CE

Celanese

$109.84

-1.17 (-1.05%)

16:26
07/19/18
07/19
16:26
07/19/18
16:26
Earnings
Celanese reports Q2 adjusted EPS $2.90, consensus $2.45 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 02

    Aug

EGP

EastGroup Properties

$95.77

1 (1.06%)

16:25
07/19/18
07/19
16:25
07/19/18
16:25
Earnings
Breaking Earnings news story on EastGroup Properties »

EastGroup Properties sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

CMCSA

Comcast

$34.91

0.88 (2.59%)

, FOXA

21st Century Fox

$46.55

-0.14 (-0.30%)

16:25
07/19/18
07/19
16:25
07/19/18
16:25
General news
Fly Intel: Wall Street's top stories for Thursday »

Stocks opened lower and…

CMCSA

Comcast

$34.91

0.88 (2.59%)

FOXA

21st Century Fox

$46.55

-0.14 (-0.30%)

DIS

Disney

$112.14

1.43 (1.29%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$46.19

-0.15 (-0.32%)

MSFT

Microsoft

$104.70

-0.38 (-0.36%)

SKYAY

Sky

$0.00

(0.00%)

IBM

IBM

$149.25

4.81 (3.33%)

AXP

American Express

$100.16

-2.82 (-2.74%)

EBAY

eBay

$34.11

-3.84 (-10.12%)

DM

Dominion Midstream

$16.75

3.1 (22.71%)

TCP

TC PipeLines

$35.22

7.55 (27.29%)

MRSN

Mersana Therapeutics

$11.24

-5.275 (-31.95%)

AA

Alcoa

$41.68

-6.22 (-12.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 01

    Aug

  • 02

    Aug

  • 06

    Aug

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

  • 08

    Aug

  • 04

    Sep

SKX

Skechers

$33.24

0.61 (1.87%)

16:23
07/19/18
07/19
16:23
07/19/18
16:23
Hot Stocks
Breaking Hot Stocks news story on Skechers »

Skechers plunges 21.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

EGP

EastGroup Properties

$95.77

1 (1.06%)

16:23
07/19/18
07/19
16:23
07/19/18
16:23
Earnings
EastGroup Properties reports Q2 FFO $1.13 ex-items, consensus $1.12 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.